Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Chem ; 286(12): 10466-75, 2011 Mar 25.
Article in English | MEDLINE | ID: mdl-21233205

ABSTRACT

The protein CrV2 is encoded by a polydnavirus integrated into the genome of the endoparasitoid Cotesia rubecula (Hymenoptera:Braconidae:Microgastrinae) and is expressed in host larvae with other gene products of the polydnavirus to allow successful development of the parasitoid. CrV2 expression has previously been associated with immune suppression, although the molecular basis for this was not known. Here, we have used time-resolved Förster resonance energy transfer (TR-FRET) to demonstrate high affinity binding of CrV2 to Gα subunits (but not the Gßγ dimer) of heterotrimeric G-proteins. Signals up to 5-fold above background were generated, and an apparent dissociation constant of 6.2 nm was calculated. Protease treatment abolished the TR-FRET signal, and the presence of unlabeled CrV2 or Gα proteins also reduced the TR-FRET signal. The activation state of the Gα subunit was altered with aluminum fluoride, and this decreased the affinity of the interaction with CrV2. It was also demonstrated that CrV2 preferentially bound to Drosophila Gα(o) compared with rat Gα(i1). In addition, three CrV2 homologs were detected in sequences derived from polydnaviruses from Cotesia plutellae and Cotesia congregata (including the immune-related early expressed transcript, EP2). These data suggest a potential mode-of-action of immune suppressors not previously reported, which in addition to furthering our understanding of insect immunity may have practical benefits such as facilitating development of novel controls for pest insect species.


Subject(s)
GTP-Binding Protein alpha Subunits/immunology , Gene Expression Regulation, Viral/immunology , Immune Tolerance/immunology , Insect Proteins/immunology , Polydnaviridae/immunology , Viral Proteins/immunology , Wasps/immunology , Animals , Drosophila melanogaster , GTP-Binding Protein alpha Subunits/genetics , GTP-Binding Protein alpha Subunits/metabolism , Insect Proteins/genetics , Insect Proteins/metabolism , Polydnaviridae/genetics , Polydnaviridae/metabolism , Rats , Viral Proteins/genetics , Viral Proteins/metabolism , Wasps/genetics , Wasps/metabolism , Wasps/virology
2.
Methods Mol Biol ; 552: 115-29, 2009.
Article in English | MEDLINE | ID: mdl-19513645

ABSTRACT

Expression of proteins in insect cells using recombinant baculoviruses has gained wide use in the G protein-coupled receptor (GPCR) community. This expression system produces high yields of functional receptor, is able to perform post-translational modifications, and is readily adaptable to large-scale culture. Here, we describe the generic methods for expressing a GPCR using baculovirus-infected insect cells, including the maintenance of insect cell culture. Data are presented for polyhedrin promoter-driven expression of a C-terminal 6 x histidine-tagged mammalian M(2) muscarinic receptor in Sf9 cells. Results demonstrate that expressed receptor could be detected and quantified using radiolabeled ligand binding, that expression was maximal at approximately 72 h post-infection, and that expression levels could be altered by addition of various ligands to cultures of infected insect cells.


Subject(s)
Baculoviridae/genetics , Receptor, Muscarinic M2/metabolism , Recombinant Proteins/metabolism , Spodoptera/metabolism , Animals , Cells, Cultured , Receptor, Muscarinic M2/genetics , Receptor, Muscarinic M2/isolation & purification , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification
3.
Methods Mol Biol ; 552: 143-51, 2009.
Article in English | MEDLINE | ID: mdl-19513647

ABSTRACT

The [(35)S]GTPgammaS binding assay to measure G protein activation following agonist binding to G protein-coupled receptors (GPCRs) remains a powerful molecular technique to substantiate traditional pharmacological values of potency, efficacy, and affinity. The method described uses membrane preparations of the alpha(2A)-adrenergic receptor and purified G protein subunits expressed in Sf9 cells, reconstituted into a functional signaling system. This technology is generic and could be used with other GPCRs to demonstrate initial signaling events following receptor activation. Agonist-stimulated [(35)S]GTPgammaS binding is measured in a 96-well plate format using scintillation counting.


Subject(s)
Cell Membrane/metabolism , Guanosine 5'-O-(3-Thiotriphosphate)/metabolism , Radioligand Assay/methods , Receptors, G-Protein-Coupled/metabolism , Humans , Receptors, G-Protein-Coupled/analysis , Sulfur Radioisotopes
4.
Anal Biochem ; 355(2): 201-12, 2006 Aug 15.
Article in English | MEDLINE | ID: mdl-16729956

ABSTRACT

G-protein-coupled receptors transduce their signals through G-protein subunits which in turn are subject to modulation by other intracellular proteins such as the regulators of G-protein signaling (RGS) proteins. We have developed a cell-free, homogeneous (mix and read format), time-resolved fluorescence resonance energy transfer (TR-FRET) assay to monitor heterotrimeric G-protein subunit interactions and the interaction of the G alpha subunit with RGS4. The assay uses a FRET pair consisting of a terbium cryptate chelate donor spectrally matched to an Alexa546 fluor acceptor, each of which is conjugated to separate protein binding partners, these being G alpha(i1):beta4gamma2 or G alpha(i1):RGS4. Under conditions favoring specific binding between labeled partners, high-affinity interactions were observed as a rapid increase (>fivefold) in the FRET signal. The specificity of these interactions was demonstrated using denaturing or competitive conditions which caused significant reductions in fluorescence (50-85%) indicating that labeled proteins were no longer in close proximity. We also report differential binding effects as a result of altered activation state of the G alpha(i1) protein. This assay confirms that interactions between G-protein subunits and RGS4 can be measured using TR-FRET in a cell- and receptor-free environment.


Subject(s)
Fluorescence Resonance Energy Transfer/methods , Heterotrimeric GTP-Binding Proteins/analysis , RGS Proteins/analysis , Fluorescence , Heterotrimeric GTP-Binding Proteins/chemistry , Heterotrimeric GTP-Binding Proteins/metabolism , Organometallic Compounds/chemistry , Organometallic Compounds/metabolism , Protein Binding , Protein Subunits/chemistry , Protein Subunits/metabolism , Quinolinium Compounds/chemistry , Quinolinium Compounds/metabolism , RGS Proteins/chemistry , RGS Proteins/metabolism , Receptors, Cell Surface/metabolism , Reproducibility of Results , Signal Transduction , Terbium/chemistry , Terbium/metabolism , Time Factors
5.
Free Radic Biol Med ; 40(9): 1592-602, 2006 May 01.
Article in English | MEDLINE | ID: mdl-16632119

ABSTRACT

The n-3 polyunsaturated fatty acids (PUFAs) found in fish oil (FO) have been shown to protect against reperfusion arrhythmias, a manifestation of reperfusion injury, which is believed to be induced by the formation of reactive oxygen species (ROS) and intracellular calcium (Ca2+) overload. Adult rats fed a diet supplemented with 10% FO had a higher proportion of myocardial n-3 PUFAs and increased expression of antioxidant enzymes compared with the saturated fat (SF)-supplemented group. Addition of hydrogen peroxide (H2O2) to cardiomyocytes isolated from rats in the SF-supplemented group increased the proportions of cardiomyocytes contracting in an asynchronous manner, increased the rate of Ca2+ influx, and increased the diastolic and systolic [Ca2+]i compared with the FO group. H2O2 exposure increased the membrane fluidity of cardiomyocytes from the FO group. These results demonstrate that dietary FO supplementation is associated with a reduction in the susceptibility of myocytes to ROS-induced injury and this may be related to membrane incorporation of n-3 PUFAs, increased antioxidant defenses, changes in cardiomyocyte membrane fluidity, and the ability to prevent rises in cellular Ca2+ in response to ROS.


Subject(s)
Calcium/metabolism , Dietary Supplements , Fish Oils/pharmacology , Myocytes, Cardiac/drug effects , Oxidative Stress/drug effects , Animals , Antioxidants/metabolism , Cell Membrane/chemistry , Cell Membrane/drug effects , Fatty Acids, Unsaturated/chemistry , Gene Expression/drug effects , Hydrogen Peroxide/pharmacology , Male , Myocytes, Cardiac/chemistry , Myocytes, Cardiac/metabolism , Oxidants/pharmacology , Oxidative Stress/physiology , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction
6.
Mol Membr Biol ; 22(6): 507-17, 2005.
Article in English | MEDLINE | ID: mdl-16373322

ABSTRACT

G-protein coupled receptors (GPCRs) form a ternary complex of agonist, receptor and G-proteins during primary signal transduction at the cell membrane. Downstream signalling is thought to be preceded by the process of dissociation of Galpha and Gbetagamma subunits, thus exposing new surfaces to interact with downstream effectors. We demonstrate here for the first time, the dissociation of heterotrimeric G-protein subunits (i.e., Galpha and Gbetagamma) following agonist-induced GPCR (alpha(2A)-adrenergic receptor; alpha(2A)-AR) activation in a cell-free assay system. alpha(2A)-AR membranes were reconstituted with the G-proteins (+/-hexahistidine-tagged) Galpha(i1) and Gbeta1gamma2 and functional signalling was determined following activation of the reconstituted receptor:G-protein complex with the potent agonist UK-14304, and [35S]GTPgammaS. In the presence of Ni(2+)-coated agarose beads, the activated his-tagged Galpha(i1)his-[35S]GTPgammaS complex was captured on the Ni(2+)-presenting surface. When his-tagged Gbeta1gamma2 (Gbeta1gamma2his) was used with Galpha(i1), the [35S]GTPgammaS-bound Galpha(i1) was not present on the Ni(2+)-coated beads, but rather, it was separated from the beta1gamma2(his)-beads, demonstrating receptor-induced dissociation of Galpha and Gbetagamma subunits. Treatment of the reconstituted alpha(2A)-AR membranes containing Gbeta1gamma2his:Galpha(i1) with imidazole confirmed the specificity for the Ni2+:G-protein surface dissociation of Galpha(i1) from Gbeta1gamma2his. These data demonstrate for the first time, the complete dissociation of the G-protein subunits and extend observations on the role of G-proteins in the assembly and disassembly of the ternary complex in the primary events of GPCR signalling.


Subject(s)
Cell Membrane/metabolism , GTP-Binding Proteins/metabolism , Membranes, Artificial , Receptors, Adrenergic, alpha-2/metabolism , Signal Transduction/physiology , Animals , Cell Membrane/chemistry , GTP-Binding Proteins/chemistry , GTP-Binding Proteins/genetics , Humans , Protein Binding , Receptors, Adrenergic, alpha-2/chemistry , Receptors, Adrenergic, alpha-2/genetics
7.
J Biomol Screen ; 10(8): 765-79, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16234342

ABSTRACT

Signal transduction by G-protein-coupled receptors (GPCRs) underpins a multitude of physiological processes. Ligand recognition by the receptor leads to activation of a generic molecular switch involving heterotrimeric G-proteins and guanine nucleotides. Signal transduction has been studied extensively with both cell-based systems and assays comprising isolated signaling components. Interest and commercial investment in GPCRs in areas such as drug targets, orphan receptors, high throughput screening, biosensors, and so on will focus greater attention on assay development to allow for miniaturization, ultra-high throughput and, eventually, microarray/biochip assay formats. Although cell-based assays are adequate for many GPCRs, it is likely that these formats will limit the development of higher density GPCR assay platforms mandatory for other applications. Stable, robust, cell-free signaling assemblies comprising receptor and appropriate molecular switching components will form the basis of future GPCR assay platforms adaptable for such applications as microarrays. The authors review current cell-free GPCR assay technologies and molecular biological approaches for construction of novel, functional GPCR assays.


Subject(s)
Drug Evaluation, Preclinical/methods , Guanosine Triphosphate/metabolism , Protein Engineering , Receptors, G-Protein-Coupled/metabolism , Biological Assay , Biosensing Techniques , Cell-Free System , Molecular Biology , Nanotechnology , Protein Array Analysis , Receptors, G-Protein-Coupled/chemistry , Receptors, G-Protein-Coupled/genetics , Signal Transduction
8.
J Nutr ; 132(9): 2506-13, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12221201

ABSTRACT

The long-chain (n-3) polyunsaturated fatty acids (PUFA) have been reported to exhibit health benefits and healing properties for the gastrointestinal tract. The aim of this study was to investigate the effects of dietary fish oil supplementation on the in vitro contractility of gut tissue. Rats (9 wk old) were fed synthetic diets supplemented with 170 g/kg Sunola oil (SO; 850 g/kg as oleic acid [18:1(n-9)]) or with 100 g/kg of the SO replaced by saturated animal fat (SF) or fish oil (FO) for 4 wk. In the colon, there was no difference in the sensitivity (50% effective concentration) or the maximal contraction among the three dietary groups induced by acetylcholine or 8-iso-prostaglandin (PG)E(2) with the rat colon being relatively insensitive to the thromboxane mimetic U-46619. However, in the ileum, the FO group had greater maximal contractions induced by acetylcholine and 8-iso-PGE(2) compared with the SO and SF groups (P < 0.05), and greater maximal contractions induced by PGE(2), PGF(2alpha) and U-46619 compared with the SF group (P < 0.05). FO feeding increased the incorporation of (n-3) PUFA (eicosapentaenoic [20:5(n-3)], docosapentaenoic [22:5(n-3)] and docosahexaenoic acids [22:6(n-3) primarily at the expense of (n-6) PUFA (linoleic [18:2(n-6)] and arachidonic acids [20:4(n-6)]) in the ileum and colon phospholipid fatty acids (P < 0.05). The FO group had a lower cecal digesta pH (P < 0.001) and a greater butyrate concentration than the SF group (P < 0.05). These results suggest that dietary (n-3) PUFA may modulate the contractility of the small intestine.


Subject(s)
Acetylcholine/pharmacology , Eicosanoids/pharmacology , Fatty Acids, Omega-3/administration & dosage , Gastrointestinal Agents/pharmacology , Ileum/drug effects , Animals , Cecum/chemistry , Colon/chemistry , Colon/drug effects , Colon/physiology , Dose-Response Relationship, Drug , Fatty Acids, Omega-3/pharmacology , Fatty Acids, Volatile/analysis , Gastrointestinal Contents/chemistry , Gastrointestinal Motility/drug effects , Hydrogen-Ion Concentration , Ileum/chemistry , Ileum/physiology , In Vitro Techniques , Male , Muscle Contraction/drug effects , Muscle Contraction/physiology , Phospholipids/chemistry , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...